Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL study.

导出 LinkOut

翻译打印收藏纠错

作者： Suzanne,Tavitian ^[1] ; Madalina,Uzunov ^[2] ; Emilie,Bérard ^[3] ; Didier,Bouscary ^[4] ; Xavier,Thomas ^[5] ; Emmanuel,Raffoux ^[6] ; Thibaut,Leguay ^[7] ; Maria Pilar,Gallego Hernanz ^[8] ; Ana,Berceanu ^[9] ; Stéphane,Leprêtre ^[10] ; Yosr,Hicheri ^[11] ; Patrice,Chevallier ^[12] ; Sarah,Bertoli ^[1] ; Véronique,Lhéritier ^[13] ; Hervé,Dombret ^[14] ; Françoise,Huguet ^[1]

作者单位： Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, CHU de Toulouse, Toulouse, France. ^[1] Department of Hematology, Assistance Publique - Hôpitaux de Paris, Paris, France. ^[2] CHU de Toulouse, UMR 1027, INSERM-Université Toulouse III, Toulouse, France. ^[3] Department of Hematology, Hopital Cochin, Paris, France. ^[4] Department of Hematology, CHU de Lyon Sud, Pierre-Bénite, France. ^[5] AP-HP, Hopital Saint-Louis, Service Hematologie Adulte, Paris, France. ^[6] Service d'hématologie clinique et thérapie cellulaire, Hôpital du Haut-Lévèque, CHU de Bordeaux, Bordeaux, France. ^[7] CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France. ^[8] Department of Hematology, CHU Besancon, Besancon, France. ^[9] Department of Hematology, Centre Henri Becquerel, Rouen, France. ^[10] Institut Paoli-Calmettes, Marseille, France. ^[11] CHU, Nantes, France. ^[12] Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), Lyon, France. ^[13] Hospital Saint-Louis, Hématologie Adulte, Paris, France. ^[14]

关键词 Acute lymphoblastic leukemia Philadelphia chromosome ponatinib